Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Investing.com - Jefferies raised its price target on Selectquote (NYSE:SLQT) to $3.00 from $2.75 while maintaining a Hold rating on the stock. The company’s shares have shown remarkable momentum, surging 34.5% in the past week. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value assessment.
The firm cited rapidly improving margins in the company’s SelectRx segment, which offset challenges in the Senior business related to the elimination of the Medicare Advantage Dual Special Needs Plan Special Enrollment Period.
Jefferies noted that Selectquote is nearly through the first year of this "profound change" and now has better visibility into the Plan Year 2026 Annual Enrollment Period.
The research firm also highlighted favorable competitive dynamics for the upcoming Annual Enrollment Period and viewed management’s decision to reduce sales representative hiring as constructive.
Despite these positive developments, Jefferies maintained its Hold rating due to concerns about Selectquote’s balance sheet and churn in the Medicare Advantage market.
In other recent news, SelectQuote Inc. reported its fourth-quarter earnings for 2025, delivering results that exceeded expectations. The company posted an earnings per share (EPS) of -$0.02, which was a significant improvement over the anticipated -$0.16. Revenue for the quarter also surpassed forecasts, reaching $345.1 million compared to the expected $343.94 million. These results were well-received by investors, reflecting positively on the company’s financial performance. The earnings surprise marks a notable development for SelectQuote, highlighting its ability to outperform analyst projections. While specific analyst reactions were not detailed, the company’s better-than-expected earnings and revenue are likely to attract attention from market observers. These recent developments underscore SelectQuote’s current financial trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.